NCT00033982View on ClinicalTrials.gov

Posaconazole to Treat Invasive Fungal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 11, 2002

Study Completion Date

February 20, 2007

Conditions
Granulomatous Disease, ChronicJob's SyndromeInfection
Interventions
DRUG

Posaconazole

Trial Locations (1)

07033

Schering-Plough Research Institute, Kenilworth

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00033982 - Posaconazole to Treat Invasive Fungal Infections | Biotech Hunter | Biotech Hunter